114 related articles for article (PubMed ID: 2979265)
1. The anti-secretory effect and pharmacokinetics of omeprazole in chronic liver disease.
McKee RF; MacGilchrist AJ; Garden OJ; Forrest JA; Carter DC
Aliment Pharmacol Ther; 1988 Oct; 2(5):429-37. PubMed ID: 2979265
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
Vinayek R; Amantea MA; Maton PN; Frucht H; Gardner JD; Jensen RT
Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole.
Andersson T; Röhss K; Bredberg E; Hassan-Alin M
Aliment Pharmacol Ther; 2001 Oct; 15(10):1563-9. PubMed ID: 11563995
[TBL] [Abstract][Full Text] [Related]
4. Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man.
Jansen JB; Lundborg P; Baak LC; Greve J; Ohman M; Stöver C; Röhss K; Lamers CB
Gut; 1988 Jan; 29(1):75-80. PubMed ID: 3343017
[TBL] [Abstract][Full Text] [Related]
5. Intravenous omeprazole in children: pharmacokinetics and effect on 24-hour intragastric pH.
Faure C; Michaud L; Shaghaghi EK; Popon M; Turck D; Navarro J; Jacqz-Aigrain E
J Pediatr Gastroenterol Nutr; 2001 Aug; 33(2):144-8. PubMed ID: 11568514
[TBL] [Abstract][Full Text] [Related]
6. Suppression of gastric acid with intravenous esomeprazole and omeprazole: results of 3 studies in healthy subjects.
Röhss K; Wilder-Smith C; Kilhamn J; Fjellman M; Lind T
Int J Clin Pharmacol Ther; 2007 Jun; 45(6):345-54. PubMed ID: 17595892
[TBL] [Abstract][Full Text] [Related]
7. Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.
Lind T; Cederberg C; Ekenved G; Haglund U; Olbe L
Gut; 1983 Apr; 24(4):270-6. PubMed ID: 6832622
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of omeprazole given by continuous intravenous infusion to patients with varying degrees of hepatic dysfunction.
Piqué JM; Feu F; de Prada G; Röhss K; Hasselgren G
Clin Pharmacokinet; 2002; 41(12):999-1004. PubMed ID: 12222996
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients.
Cederberg C; Thomson AB; Mahachai V; Westin JA; Kirdeikis P; Fisher D; Zuk L; Marriage B
Gastroenterology; 1992 Sep; 103(3):913-8. PubMed ID: 1499942
[TBL] [Abstract][Full Text] [Related]
10. Acid secretory responses and parietal cell sensitivity following duodenal ulcer healing with omeprazole, sucralfate, and Maalox.
Johnston DA; Marks IN; Young GO; Tigler-Wybrandi NA; Bridger S; Zak J
Am J Med; 1991 Aug; 91(2A):91S-94S. PubMed ID: 1882910
[TBL] [Abstract][Full Text] [Related]
11. Influence of acid secretory status on absorption of omeprazole from enteric coated granules.
Andersson T; Bergstrand R; Cederberg C
Br J Clin Pharmacol; 1991 Mar; 31(3):275-8. PubMed ID: 2054268
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole in elderly duodenal ulcer patients: relationship between reduction in gastric acid secretion and fasting plasma gastrin.
Lind T; Cederberg C; Olausson M; Olbe L
Eur J Clin Pharmacol; 1991; 40(6):557-60. PubMed ID: 1884735
[TBL] [Abstract][Full Text] [Related]
13. Effect of once daily intravenous and oral omeprazole on 24-hour intragastric acidity in healthy subjects.
Cederberg C; Röhss K; Lundborg P; Olbe L
Scand J Gastroenterol; 1993 Feb; 28(2):179-84. PubMed ID: 8441912
[TBL] [Abstract][Full Text] [Related]
14. Effect of omeprazole and cimetidine on healing of chronic gastric ulcers and gastric acid secretion in rats.
Skov Olsen P; Therkelsen K; Poulsen SS
Tohoku J Exp Med; 1988 Aug; 155(4):305-10. PubMed ID: 3232144
[TBL] [Abstract][Full Text] [Related]
15. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
[TBL] [Abstract][Full Text] [Related]
16. Acid secretory capacity and plasma gastrin concentration after administration of omeprazole to normal subjects.
Sharma B; Axelson M; Pounder RP; Lundborg P; Ohman M; Santana A; Talbot M; Cederberg C
Aliment Pharmacol Ther; 1987 Feb; 1(1):67-76. PubMed ID: 2979214
[TBL] [Abstract][Full Text] [Related]
17. Effect of low-dose omeprazole on gastric acid secretion in duodenal ulcer patients.
McLauchlan G; Crean GP; McColl KE
Aliment Pharmacol Ther; 1988 Jun; 2(3):263-8. PubMed ID: 2979250
[TBL] [Abstract][Full Text] [Related]
18. Effect of omeprazole on gastric acid secretion and plasma gastrin.
Olbe L; Cederberg C; Lind T; Olausson M
J Gastroenterol Hepatol; 1989; 4 Suppl 2():19-25. PubMed ID: 2491358
[TBL] [Abstract][Full Text] [Related]
19. The effect of omeprazole on the pharmacokinetics of metronidazole and hydroxymetronidazole in human plasma, saliva and gastric juice.
Jessa MJ; Goddard AF; Barrett DA; Shaw PN; Spiller RC
Br J Clin Pharmacol; 1997 Sep; 44(3):245-53. PubMed ID: 9296318
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole.
Gillen D; Wirz AA; Neithercut WD; Ardill JE; McColl KE
Gut; 1999 Apr; 44(4):468-75. PubMed ID: 10075952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
